Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats

Cancer Research

Volumn 56, Issue 11, 1996, Pages 2602-2606

  Shirasaka, Tetsuhiko ^a   Nakano, Koushi ^a   Takechi, Teiji ^a   Satake, Hiroyasu ^a   Uchida, Junji ^a   Fujioka, Akio ^a   Saito, Hitoshi ^a   Okabe, Hiroyuki ^a   Oyama, Kiyomi ^a   Takeda, Setsuo ^a   Unemi, Norio ^a   Fukushima, Masakazu ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE; 5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; OXONIC ACID; TEGAFUR; THYMIDYLATE SYNTHASE; URACIL;

ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CANCER INHIBITION; CANCER TRANSPLANTATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; LUNG METASTASIS; LYMPH NODE METASTASIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TUMOR GROWTH;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL DIVISION; COLONIC NEOPLASMS; DRUG COMBINATIONS; FLUOROURACIL; HUMANS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; OXONIC ACID; PRODRUGS; PYRIDINES; RATS; RATS, NUDE; RNA; TEGAFUR; TRANSPLANTATION, HETEROLOGOUS;

EID: 9344248389     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Pinedo, H H., and Peters, G. F. J. Fluorouracil: biochemistry and pharmacology. J. Clin. Oncol., 6: 1653-1664, 1988.
2. Heidelberger, C. Fluorinated pyrimidines and their nucleosides In: A. C. Sartorelli and D. Johns (eds.), Antineoplastic and Immunosuppressive Agents Handbook of Experimental Pharmacology, Vol. 38, pp 193-231, New York: Springer-Verlag, 1975
3. Heidelberger, C , Dannenberg, P. V., and Moran, R. G. Fluorinated pyrimidines and their nucleosides. Adv Enzymol. Relat. Areas Mol. Biol., 54: 57-119, 1989.
4. Duschinsky, R., Pleven, E., and Heidelberger, C. The synthesis of 5-fluoropyrimidines. J. Am. Chem. Soc., 79: 4559-4560, 1957.
5. Tatsumi, K., Fukushima, M., Shirasaka, T., and Fujii, S Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extract. Jpn. J. Cancer Res , 78. 748-755, 1987.
6. Shirasaka, T., Fukushima, M., Shimamoto, Y., and Kimura, K. Preclinical studies on S-1, a new oral tegafur plus modulators optimal molar ratio and antitumor activity Proc. Int. Congr. Chemother., 18. 927, 1993
7. Shirasaka, T , Shimamoto, Y., and Fukushima, M Inhibition of oxonic acid on gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats Cancer Res., 53: 4004-4009, 1993.
8. Povlsen, C O., and Jacobsen, G. K. Chemotherapy of the human malignant melanoma transplanted in the nude mouse. Cancer Res., 35: 2790-2796, 1975.
9. Osieka, R , Houchens, D P , Goldin, A., and Johnson, R. K Chemotherapy of human colon cancer xenografts in athymic nude mice Cancer (Phila). 40: 2640-2650, 1977.
10. Kubota, T., Shimosato, Y., and Nagai, K., Experimental chemotherapy of carcinoma of the human stomach and colon serially transplanted in nude mice Gann, 69: 299-309, 1978
11. Naito, S , von Eschenbach, A. C., Giavazzi, R., and Fidler, I J. Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res., 46: 4109-4115, 1986.
12. Bresalier, R. S., Raper, S. E., Hujanen, E S., and Kim, Y. S A new animal model for human colon cancer metastasis Int. J. Cancer, 39. 625-630, 1987.
13. Bresalier, R. S , Niv, Y , Byrd, J. C., Duh, Q-Y , Toribara, N W , Rockwell, R. W., Dahiya, R., and Kim, Y. S. Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis J Clin Invest , 87: 1037-1045, 1991.
14. Fu, X , Besterman, J M., Monosov, A., and Hoffman, R. M. Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Proc. Natl. Acad. Sci. USA, 88: 9345-9349, 1991.
15. Furukawa, T., Kubota, T., Watanabe, M., Kuo, T-H., Nishibori, H., Saikawa, Y., Kase, S., Tanino, H , Teramoto, T., Ishibiki, K., and Kitajima, M. A metastatic model of human colon cancer constructed using cecal implantation of cancer-tissue in nude mice. Jpn. J. Surg., 23: 420-423, 1993.
16. McLemore, T. L., Eggleston, J. C., Shoemaker, R. H., Abbott, B J., Bohlman, M. E., Liu, M. C , Fine, D. L , Mayo, J G., and Boyd, M R Comparison of intrapulmonary, percutaneous intrathoracic, and subcutaneous models for the propagation of human pulmonary and nonpulmonary cancer cell lines in athymic nude mice. Cancer Res., 48. 2880-2886, 1988.
17. McLemore, T. L., Liu, M C., Blacker, P. C., Gregg, M , Alley, M. C., Abbott, B J., Shoemaker, R. H., Bohlman, M. E., Litterst, C C., Hubbard, W. C., Brennan, R H., MacMahon, J. B., Fine, D. L., Eggleston, J. C., Mayo, J. G., and Boyd, M. R. Novel intrapulmonary model for orthotopic propagation of human lung cancers in athymic nude mice. Cancer Res., 47: 5132-5140, 1987.
18. Fu, X., Herrera, H., and Hoffman, R. M. Orthotopic growth and metastasis of human prostate carcinoma in nude mice after transplantation of histologically-intact tissue. Int. J. Cancer., 52: 987-990, 1992
19. Fu, X., Le, P. and Hoffman, R. M. A metastatic orthotopic-transplant-nude-mouse model of human patient breast cancer. Anticancer Res., 13: 901-904, 1993.
20. Furukawa, T., Kubota, T., Watanabe, M., Kitajima, M., and Hoffman, R. M. A novel "patient-like" treatment model of human pancreatic cancer constructed using orthotopic transplantation of histologically intact human tumor tissue in nude mice Cancer Res., 53: 3070-3072, 1993.
21. Paget, S. The distribution of secondary growths in cancer of the breast. Lancet, 1: 571-573, 1889.
22. Kurihara, M., Izumi, T., Yoshida, S., Ohkubo, T., Suga, S., Kiyohashi, A., Yaosaka, T., Takahashi, H., Ito, T., Sasai, T., Akiya, T , Akazawa, S., Betsuyaku, T , and Taguchi, S A cooperative randomized study on tegafur plus mitomycin C versus combined tegafur and uracil plus mitomycin C in the treatment of advanced gastric cancer. Jpn. J. Cancer Res., 82: 613-620, 1991.
23. Pazdur, R., Lassere, Y., Rhodes, V., Ajani, J. A , Sugarman, S. M., Patt, Y. Z., Jones, D. V., Jr., Marcowitz, A. B., Abbruzzese, J. L., and Bready, B. Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma J. Clin Oncol , 12: 2296-2300, 1994.
24. Ichinose, Y., Takanashi, N., Yano, T., Asoh, H , Yokoyama, H., Tayama, K., Hara, N., and Ohta, M. A phase II trial of oral tegafur and uracil plus cisplatin in patients with inoperable nonsmall cell lung cancer. Cancer (Phila.), 75: 2677-2680, 1995.
25. Kubota, Y , Hosaka, M , Fukushima, S., and Kondo, I Prophylactic oral UFT therapy for superficial bladder cancer. Cancer (Phila.), 71: 1842-1845, 1993.
26. Morikawa, K., Walker, S. M., Jessup, J. M , and Fidler, I. J. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res., 48: 1943-1948, 1988.
27. Morikawa, K., Walker, S. M., Nakajima, M., Pathak, S , Jessup, J. M., and Fidler, I. J Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res., 48: 6863-6871, 1988
28. Marunaka, T., Umeno, Y , Yoshida, K., Nagamachi, M., Minami, Y., and Fujii, S High-pressure liquid chromatographic determination of Ftorafur[1-(tetrahydro-2-furany])-5-fluorouracil] and GLC-mass spectrometric determination of 5-fluorouracil and uracil in biological materials after oral administration of uracil plus Ftorafur. J. Pharm. Sci., 69. 1296-1300, 1980
29. Uchida, J., Umeno, Y., and Takeda, S. Significance of measuring 5-fluorouracil incorporated into RNA of tumor tissue as a parameter for the antitumor activity of 5-fluorouracil and its derivatives. Jpn. J. Cancer Chemother., 19: 677-683, 1992. (in Japanese with English summary)
30. Schneider, W. C. Phosphorus compounds in animal tissues. III. A comparison of methods for the estimation of nucleic acids. J. Biol. Chem , 227: 164-747, 1946.
31. Spears, C. P., Shahinian, A. H., Moran, R. G., Heidelberger, C., and Corbert, T. In vivo kinetics of thymidylate synthetase inhibition in 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas. Cancer Res., 42: 450-456, 1982.
32. Morodomi, T., Isomoto, H., Akagi, Y., Araki, Y., Ogata, Y., Shirouzu, K , and Kakegawa, T. The production of spontaneous lung metastasis model from transplanted colon carcinoma in nude rat. preliminary report. Nippon Geka Gakkai Zasshi, 94: 1319, 1993. (in Japanese)
33. Lokich, J. J., Ahlgren, J. D., Gullo, J J , Philips, J. A., and Fryer, J. G. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a mid-atlantic oncology program study J. Clin. Oncol. 7: 425-432, 1989.
34. Moyniham, T., Hansen, R., Anderson, T., Quebbeman, E., Beatty, P., Ausman, R , Ritch, P., Chitamber, C , and Vukelich, M. Continuous 5-fluorouracil infusion in advanced gastric carcinoma. Am. J. Clin. Oncol , 11, 461-464, 1988.
35. Barbounis, V P , Kalofonos, H P., Munro, A J., McKenzie, C. G., Sackier, J M., and Epenetos, A. A. Treatment of colorectal cancer and other malignancies with continuous infusion of 5-fluorouracil. Anticancer Res., 9 33-40, 1989.
36. Huan, S., Pazdur, R., Singhakowinta, A., Samal, B., and Vaitkevicius, V. K. Low-dose continuous infusion 5-fluorouracil, evaluation in advanced breast carcinoma Cancer (Phila.), 63. 419-422, 1989.
37. Hass, N. B , Hines, J. B., Hudes, G R., Johnston, N., Ozols, R. F., and O'Dwyer, P. J. Phase I trial of 5-fluorouracil by 24-hour infusion weekly. Invest. New Drugs, 11 181-185, 1993.
38. Anderson, N R , and Lokich, J J. Prolonged venous infusion of fluorouracil in colorectal cancer Pharmacological rationale, clinical experience and future directions. In: A Abad (ed.), Medical Treatment of Colorectal Cancer, pp. 144-173. Madrid: Graficas Monterreina, 1991